A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ₩134,236.13, with a 24-hour trading volume of ₩799.45B. The asset's market cap is ₩416.2T, after moving -1.63% in the last day.
Tokenized AstraZeneca PLC is trading at ₩133,454.69, with a tokenized market cap of ₩1B and a 24-hour trading volume of ₩97.4M. The tokenized asset has moved -1.98% in the past 24 hours.